Reaction Details |
| Report a problem with these data |
Target | Protease |
---|
Ligand | BDBM50479982 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_544292 (CHEMBL1020430) |
---|
Ki | 0.008±n/a nM |
---|
Citation | Hazen, R; Harvey, R; Ferris, R; Craig, C; Yates, P; Griffin, P; Miller, J; Kaldor, I; Ray, J; Samano, V; Furfine, E; Spaltenstein, A; Hale, M; Tung, R; St Clair, M; Hanlon, M; Boone, L In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV. Antimicrob Agents Chemother51:3147-54 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Protease |
---|
Name: | Protease |
Synonyms: | n/a |
Type: | Enzyme |
Mol. Mass.: | 10904.79 |
Organism: | Human immunodeficiency virus 1 (HIV-1) |
Description: | Q9YQ12 |
Residue: | 99 |
Sequence: | PQITLWQRPFVTIKIEGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD
QIVIEICGKKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
|
|
|
BDBM50479982 |
---|
n/a |
---|
Name | BDBM50479982 |
Synonyms: | Aptivus | CHEBI:63628 | Tipranavir | U-140690 | US10806794, Compound Tipranavir |
Type | Small organic molecule |
Emp. Form. | C31H33F3N2O5S |
Mol. Mass. | 602.664 |
SMILES | CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1 |t:15| |
Structure |
|